COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 243: Articles 2421-2430  | Next

Comparative transcriptomic analyses of peripheral blood mononuclear cells of patients with non-pneumonia and severe pneumonia at 1 year-Long-COVID-19
Kayalar, O., Cetinkaya, P. D., Eldem, V., Argun Baris, S., Kokturk, N., Kuralay, S. C., Rajabi, H., Konyalilar, N., Mortazavi, D., Korkunc, S. K., Erkan, S., Aksoy, G. T., Eyikudamaci, G., Deniz, P. P., Baydar Toprak, O., Yildiz Gulhan, P., Sagcan, G., Kose, N., Tomruk Erdem, A., Fakili, F., Ozturk, O., Basyigit, I., Boyaci, H., Azak, E., Ulukavak Ciftci, T., Oguzulgen, I. K., Ozger, H. S., Aysert Yildiz, P., Hanta, I., Ataoglu, O., Ercelik, M., Cuhadaroglu, C., Kuzu Okur, H., Tor, M. M., Nurlu Temel, E., Kul, S., Tutuncu, Y., Itil, O., Bayram, H.
10.1101/2023.12.12.23299822 — Posted: 2023-12-14
Inactivation of the Niemann Pick C1 cholesterol transporter 1 (NPC1) restricts SARS-CoV-2 infection
La Rosa, P., Tiberi, J., Palermo, E., Tiano, S., Cortese, M., Hiscott, J., Fiorenza, M. T.
10.1101/2023.12.13.571570 — Posted: 2023-12-14
Self-inhibiting percolation and viral spreading in epithelial tissue
Xu, X., Nielsen, B. F., sneppen, k.
10.1101/2023.12.12.571279 — Posted: 2023-12-13
Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform
Costello, R. E., Waller, K. M., Smith, R., Mells, G. F., Wong, A. Y., Schultze, A., Mahalingasivam, V., Herrett, E., Zheng, B., Lin, L.-Y., Mehrkar, A., Bacon, S. C., Goldacre, B., Tomlinson, L. A., Tazare, J., Rentsch, C. T.
10.1101/2023.12.11.23299191 — Posted: 2023-12-13
The availability, use and impact of workplace mental health supports during the COVID-19 pandemic in a Canadian prospective cohort of healthcare workers.
Ruzycki, S., Adisesh, A., Burstyn, I., Durand-Moreau, Q., Labreche, F., Zadunayski, T., Cherry, N.
10.1101/2023.12.12.23299862 — Posted: 2023-12-13
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023
van Werkhoven, H., Valk, A.-W., Smagge, B., de Melker, H. E., Knol, M. J., Hahne, S., van den Hof, S., de Gier, B.
10.1101/2023.12.12.23299855 — Posted: 2023-12-13
Impact of the population age, testing and vaccination levels on the numbers of COVID-19 cases and deaths per capita and case fatality risks
Nesteruk, I.
10.1101/2023.12.09.23299758 — Posted: 2023-12-13
Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults
Oyegun, E. I.
10.1101/2023.12.11.23299148 — Posted: 2023-12-13
The impact of COVID-19 vaccines on patients with immune thrombocytopenic purpura:A protocol for a systematic review and meta-analysis
Li, Y., Kong, D., Ding, Y., Wang, J.
10.1101/2023.12.09.23298879 — Posted: 2023-12-13
Syncytia Formation Promotes Virus Resistance to Interferon and Neutralizing Antibodies
Li, T., Kang, I., Hu, Z., Gibbs, J., Ye, C., Kosik, I., Shi, G., Holly, J., Kosikova, M., Compton, A. A., Martinez-Sobrido, L., Johnson, R., Hang, X., Yewdell, J. W.
10.1101/2023.12.12.571262 — Posted: 2023-12-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).